A small NYC-led cancer trial has achieved a result reportedly never before seen - the total remission of cancer in all of its patients.
To be sure, the trial — led by doctors at Memorial Sloan Kettering and backed by drug maker GlaxoSmithKline — has only completed treatment of 12 patients, with a specific cancer in its early stages and with a rare mutation as well. READ MORE
